Skip to main content
A

Apex Biotechnology Corp. — Investor Relations & Filings

Ticker · 1733 TW Manufacturing
Filings indexed 1,519 across all filing types
Latest filing 2026-03-17 Regulatory Filings
Country TW Taiwan
Listing TW 1733

About Apex Biotechnology Corp.

https://www.apexbio.com.tw

ApexBio is a developer and manufacturer of in-vitro diagnostic (IVD) solutions, specializing in biosensor technology. The company provides a comprehensive range of products, including self-monitoring blood glucose systems, multi-functional home health management devices, and point-of-care testing (POCT) equipment. Its core operations encompass the research, development, production, and global distribution of diagnostic tools designed for both home care and professional clinical environments. Recognized for its innovation in home-care blood glucose monitoring, the company leverages its technological foundation to offer integrated solutions for chronic disease management and professional clinical trials. ApexBio focuses on enhancing healthcare accessibility through reliable diagnostic innovation and a full range of IVD services.

Recent filings

Filing Released Lang Actions
114年第4季大陸投資
Regulatory Filings
2026-03-17 Chinese
114年度財務比率
Regulatory Filings
2026-03-17 Chinese
114年度應收帳款周轉率
Regulatory Filings
2026-03-16 Chinese
114年度存貨週轉率
Regulatory Filings
2026-03-16 Chinese
114年度毛利率
Regulatory Filings
2026-03-16 Chinese
114年度營益分析
Regulatory Filings
2026-03-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.